Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23882,84,1.16 [0.88-1.53],0.3018321283880071
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24387,129,1.11 [0.88-1.39],0.3862947894579108
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",24172,891,1.12 [1.03-1.23],0.0082774805580702
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Candidiasis,24409,266,1.04 [0.89-1.22],0.6435446010792062
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23716,2411,1.09 [1.03-1.15],0.0012374192693002
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23940,1825,1.06 [1.00-1.13],0.0509483985154722
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,24228,864,1.12 [1.03-1.22],0.011730302294759
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24340,38,0.97 [0.63-1.48],0.8808584312962395
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23293,562,1.12 [1.01-1.25],0.0367669214980071
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22504,532,1.17 [1.05-1.31],0.00609601088995
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22722,148,1.06 [0.86-1.32],0.5815076800577699
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18146,1063,1.11 [1.03-1.21],0.0086292442637186
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22526,249,1.22 [1.03-1.43],0.0176374671148519
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24373,1009,1.11 [1.02-1.20],0.0121346534078097
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Mycoses,24467,324,1.04 [0.90-1.21],0.5523246951431133
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23825,544,1.16 [1.04-1.30],0.006762283721674
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24415,617,1.11 [1.00-1.23],0.044064254069394
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23495,131,1.09 [0.87-1.37],0.4660377116008912
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24509,29,1.18 [0.73-1.90],0.5070404674406059
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24342,544,1.09 [0.98-1.22],0.1160843790999725
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24367,65,1.18 [0.85-1.62],0.3222763616129647
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24419,151,1.29 [1.05-1.58],0.0168864370779842
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24404,136,1.26 [1.01-1.57],0.0376062628289025
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23584,303,1.23 [1.07-1.43],0.0046833659388526
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23490,209,1.08 [0.90-1.29],0.3999193810333631
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23429,65,1.20 [0.87-1.64],0.2686456976516996
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24482,46,0.98 [0.67-1.44],0.929186774725251
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24453,115,0.90 [0.70-1.15],0.3947218628885862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral warts,24377,39,0.66 [0.43-1.03],0.068456444514723
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24382,44,1.09 [0.74-1.62],0.6489285607971318
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm,24248,278,1.17 [1.00-1.36],0.0474793555576914
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24432,64,1.25 [0.91-1.72],0.1744108467078646
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24403,67,1.36 [1.00-1.85],0.0505432116667183
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10950,37,1.10 [0.72-1.69],0.64520498744172
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",24328,1030,1.00 [0.92-1.09],0.9847371084359016
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of meninges,24497,44,1.33 [0.91-1.96],0.1423918406001537
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24477,49,0.87 [0.60-1.27],0.4633664487454088
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24487,78,1.15 [0.86-1.54],0.3501673649200244
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of ovary,13502,86,1.10 [0.83-1.45],0.522821237533493
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24501,245,0.92 [0.78-1.09],0.3311876735357759
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Caecum,24497,185,1.07 [0.88-1.29],0.5019761634960838
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24442,48,1.14 [0.79-1.65],0.4867965213282427
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Descending colon,24504,157,0.83 [0.67-1.03],0.0952728078440159
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Rectum,24468,258,0.95 [0.80-1.12],0.5195358419621456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24438,476,0.97 [0.86-1.09],0.5674487895549003
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24502,271,0.98 [0.84-1.15],0.8113838827317232
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Carcinoma in situ of breast,11571,75,0.66 [0.48-0.91],0.0100971975938487
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11611,85,0.77 [0.57-1.03],0.0753766024139605
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",21126,29,1.45 [0.91-2.30],0.1168598171372678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",21132,35,0.91 [0.58-1.41],0.6608187508173964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24468,96,0.86 [0.66-1.13],0.2887519538854348
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma, any site",24468,94,0.87 [0.66-1.14],0.3247405767903394
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Leiomyoma of uterus,12940,359,0.98 [0.85-1.13],0.8024860800827921
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Lung cancer and mesothelioma,18170,158,0.69 [0.56-0.86],0.0008969667031776
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Lymphoid leukaemia,21124,27,1.77 [1.10-2.86],0.0183976632038446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21230,133,1.08 [0.86-1.36],0.4854447880482144
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",21174,77,1.10 [0.82-1.48],0.516784095858305
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11661,71,1.07 [0.78-1.45],0.6842445194830518
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",21142,45,0.82 [0.55-1.22],0.3249947005657402
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",21150,53,1.09 [0.76-1.56],0.6288681594471102
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",21161,64,1.22 [0.88-1.68],0.2344937174952921
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11639,49,1.40 [0.97-2.02],0.0689814910122293
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",21151,54,1.21 [0.85-1.72],0.2834267055196697
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9864,357,1.11 [0.97-1.27],0.1416352910992148
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",21183,86,1.13 [0.86-1.50],0.3871665227381825
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",21145,48,1.29 [0.89-1.86],0.1763367235693337
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,21153,56,0.87 [0.61-1.23],0.4261243150542828
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi,24299,192,1.06 [0.88-1.28],0.5183419678386086
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi of trunk,24467,86,1.02 [0.77-1.35],0.8955477491722178
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanoma in situ,21108,40,1.40 [0.93-2.09],0.1035867745957919
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",21152,55,1.02 [0.72-1.46],0.891026198227602
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21201,104,1.24 [0.96-1.59],0.0939667638282021
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",21203,106,1.03 [0.80-1.31],0.8339639286224423
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",21156,59,1.23 [0.88-1.73],0.2176432422364676
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Other benign neoplasms of skin,24349,134,1.15 [0.92-1.44],0.2128078375387861
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21666,569,1.00 [0.89-1.11],0.940736061337302
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21696,599,0.99 [0.89-1.11],0.9252461863160256
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24252,265,1.07 [0.91-1.25],0.4147664298357645
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,23256,43,1.21 [0.82-1.79],0.3437283204975223
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,24054,67,1.25 [0.91-1.70],0.16585536239003
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23792,1957,1.12 [1.06-1.19],0.000130342997315
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23476,20,0.85 [0.47-1.52],0.5791343686519039
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,24201,28,1.46 [0.92-2.34],0.1110282407053531
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,24110,897,1.12 [1.03-1.23],0.0080557767805382
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,24110,897,1.12 [1.03-1.23],0.0080557767805382
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,23262,49,1.10 [0.76-1.59],0.6281998197400283
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,24262,806,1.16 [1.06-1.27],0.0017200969954368
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,24266,93,1.11 [0.85-1.45],0.4622509072852701
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,24036,49,1.20 [0.83-1.74],0.3218155249037358
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,24026,39,1.29 [0.86-1.94],0.2240884925929488
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24340,167,0.97 [0.80-1.19],0.8041576041140182
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24439,59,1.34 [0.96-1.86],0.0820906712987221
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24316,143,0.90 [0.72-1.12],0.3332983633695651
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23518,62,1.09 [0.79-1.51],0.6065713741240768
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21029,180,1.06 [0.87-1.28],0.5853235113365814
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22783,109,1.23 [0.97-1.57],0.0900527535545938
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22799,125,1.18 [0.94-1.48],0.1538277262164577
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20882,33,1.78 [1.15-2.74],0.0092854625021148
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22742,64,1.07 [0.77-1.48],0.6873606766512763
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22438,122,0.93 [0.74-1.18],0.5604226953945275
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",24380,146,1.15 [0.93-1.43],0.1837964142326446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,24281,47,0.81 [0.55-1.19],0.2837817346434543
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,24265,31,1.16 [0.73-1.85],0.5190368434487157
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,24142,1464,1.05 [0.98-1.13],0.128009922437895
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21941,1424,1.06 [0.99-1.13],0.1191480437675669
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20888,39,1.13 [0.75-1.72],0.553082640803676
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23056,52,0.84 [0.58-1.22],0.3693997963198593
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21015,166,1.43 [1.17-1.74],0.0003795602026252
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20905,56,1.25 [0.89-1.76],0.197645524386085
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22976,2127,1.17 [1.11-1.24],1.7434628558905152e-08
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20957,108,1.09 [0.85-1.40],0.4779758275969527
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,21197,348,1.25 [1.09-1.43],0.0014677161575808
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24422,230,1.21 [1.03-1.44],0.0240778223749152
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,24285,93,1.48 [1.14-1.93],0.0030485915305736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20941,92,1.37 [1.05-1.78],0.0187242073077012
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20884,35,1.08 [0.69-1.67],0.7420321833305682
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24132,1128,1.11 [1.03-1.20],0.0063271890002446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20964,115,1.19 [0.94-1.51],0.1560734764490962
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20986,137,1.12 [0.90-1.39],0.3176549520161062
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21194,345,1.11 [0.97-1.28],0.1363518795754133
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20906,57,1.11 [0.79-1.57],0.5411116401060446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,24280,88,1.48 [1.13-1.94],0.0043967740002132
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,21116,267,1.15 [0.98-1.35],0.0781148698227678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,21124,275,1.19 [1.02-1.39],0.0253541282989109
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,22367,51,1.19 [0.83-1.71],0.3331736457165693
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23883,3034,1.15 [1.09-1.20],1.0222960651095491e-08
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,23031,27,0.93 [0.56-1.55],0.7887752962492841
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,23057,53,1.24 [0.87-1.77],0.2262547616600255
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24349,1711,1.00 [0.94-1.06],0.9081254141893168
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24351,1707,1.00 [0.93-1.06],0.8919155214183312
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,23035,31,1.71 [1.10-2.66],0.0179595222963889
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,24220,1093,1.09 [1.01-1.18],0.0337636912127859
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21646,797,1.16 [1.06-1.27],0.0014618125395128
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24500,109,0.96 [0.75-1.24],0.774866295072434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,24264,30,0.98 [0.61-1.56],0.9186733441531808
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,23210,83,1.01 [0.76-1.35],0.9230644799555572
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,23228,101,1.20 [0.93-1.56],0.1566701618646313
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20961,112,1.42 [1.12-1.81],0.0043219606626407
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22907,109,1.26 [0.99-1.61],0.0563102619139991
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1526,59,0.95 [0.68-1.34],0.7835760202503775
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1623,169,1.01 [0.83-1.23],0.9293121892554876
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22835,37,1.13 [0.76-1.70],0.5429134614831786
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1500,33,1.41 [0.89-2.22],0.1438038099926736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,24147,1349,1.16 [1.08-1.24],2.4992875830142728e-05
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,24295,61,0.85 [0.61-1.20],0.3619181425014351
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22565,249,1.02 [0.86-1.20],0.8347494591062818
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21207,358,1.20 [1.05-1.38],0.0072935479655669
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24429,150,0.90 [0.73-1.12],0.3482386525056942
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23839,47,0.99 [0.68-1.45],0.9693239231270584
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Angina pectoris,23383,708,1.05 [0.96-1.16],0.2893283213548067
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23884,92,1.07 [0.82-1.40],0.617867493399072
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23822,30,1.28 [0.81-2.03],0.2911324731761343
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23890,98,1.22 [0.95-1.58],0.1209251802582132
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17397,816,1.03 [0.94-1.13],0.4873310831009331
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,AV-block,22293,164,0.93 [0.76-1.15],0.5111708153039474
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24480,233,0.90 [0.76-1.07],0.2267428176059362
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiac arrest,16677,96,1.25 [0.96-1.61],0.0952343983897341
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiomyopathy,22248,119,0.97 [0.77-1.24],0.8220021854827345
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",22205,76,0.96 [0.71-1.30],0.7953973040130594
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24511,14,0.42 [0.20-0.88],0.0208222863528777
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Conduction disorders,22607,478,1.01 [0.90-1.14],0.8648877181549293
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23856,1191,1.16 [1.08-1.25],6.455834652299934e-05
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22772,5391,1.09 [1.05-1.12],5.1390607991895485e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23481,158,0.91 [0.74-1.12],0.3747298289922456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Endocarditis,22170,41,0.80 [0.53-1.22],0.2988809712540309
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24401,462,1.15 [1.02-1.30],0.0203583069254618
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertension,23279,4386,1.09 [1.05-1.14],8.925088243926953e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23288,4395,1.09 [1.05-1.14],9.346555579177256e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24352,49,0.67 [0.46-0.99],0.0446980666270101
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18975,82,1.06 [0.80-1.42],0.6738660343117662
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18935,42,1.32 [0.89-1.95],0.1659171705394926
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypotension,24419,610,1.04 [0.93-1.15],0.5068227282179403
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,24040,59,1.06 [0.76-1.48],0.7450425681576487
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",24008,1333,1.14 [1.06-1.22],0.0003643790139393
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",24314,279,1.05 [0.90-1.22],0.5431296410397302
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Left bundle-branch block,22316,187,1.21 [1.00-1.46],0.0467469596336515
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24287,537,1.12 [1.00-1.25],0.0489837394183419
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",23112,437,1.17 [1.04-1.33],0.0101509644901184
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24462,105,1.04 [0.81-1.34],0.7665215069654672
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24496,183,1.18 [0.98-1.43],0.0792396135555846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Oesophageal varices,23354,31,0.64 [0.39-1.04],0.0697781468218267
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other aneurysm,23835,43,0.68 [0.45-1.03],0.0682581019792805
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arrhythmias,22356,227,1.04 [0.88-1.24],0.6518184475859796
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23854,62,1.25 [0.91-1.72],0.1700650055022064
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23925,133,0.99 [0.79-1.24],0.9519655969919036
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,22244,115,0.79 [0.62-1.02],0.0675367844752213
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other disorders of veins,23387,64,0.85 [0.61-1.19],0.3455438374413673
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,23369,46,1.00 [0.68-1.47],0.9897317993773472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23814,34,0.97 [0.62-1.52],0.9089203012075896
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,23405,82,0.87 [0.64-1.17],0.341720382165641
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22655,526,1.14 [1.01-1.27],0.0264239162503874
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23850,41,0.72 [0.47-1.10],0.1247266450049264
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,24103,311,1.11 [0.96-1.29],0.1520607728607258
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24106,139,1.15 [0.93-1.43],0.1977430158802725
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23991,211,1.08 [0.91-1.30],0.3668124796400054
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16797,216,0.99 [0.83-1.19],0.9273804198022292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23956,186,1.15 [0.95-1.38],0.1508954687772392
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23541,218,0.99 [0.83-1.18],0.8838457217072819
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Pulmonary embolism,24266,299,1.09 [0.94-1.26],0.2657470570822567
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24472,288,1.06 [0.91-1.23],0.4629611237163862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Right bundle-branch block,22281,152,0.90 [0.73-1.11],0.3310864081182855
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24103,136,1.16 [0.93-1.44],0.1964242900516083
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23884,104,1.07 [0.83-1.38],0.5899292997052377
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",24307,326,1.03 [0.90-1.19],0.6533032524454052
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",24284,359,1.01 [0.88-1.16],0.8422441331535743
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,24020,51,0.97 [0.68-1.40],0.888314230390547
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23841,50,0.99 [0.69-1.44],0.9664348300352285
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Transient ischemic attack,24150,115,1.05 [0.82-1.33],0.7191119968025019
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23910,160,1.03 [0.84-1.26],0.8104186455928801
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Varicose veins,23599,276,0.92 [0.79-1.08],0.3298956891825819
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23802,46,1.15 [0.79-1.69],0.4649094918551147
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24353,463,1.03 [0.91-1.16],0.659223399457693
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24364,331,1.03 [0.90-1.19],0.6616481474963742
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21819,1257,1.10 [1.02-1.19],0.0095243059606387
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Any mental disorder,23829,3267,1.05 [1.01-1.10],0.0278480417468035
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24308,385,1.06 [0.93-1.21],0.3687104937559444
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22057,1495,1.06 [0.99-1.13],0.1099250422951462
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20640,78,0.97 [0.72-1.30],0.8147489734963067
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Smoking dependency,24022,1369,1.05 [0.98-1.13],0.1775856357250781
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22130,1568,1.05 [0.98-1.12],0.1724951089990288
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Vascular dementia,24409,16,0.90 [0.46-1.74],0.7452072471441984
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Alzheimer disease,24510,64,0.78 [0.56-1.09],0.1468992062492092
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Bell's palsy,23021,67,0.94 [0.68-1.29],0.6866478442081403
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23384,430,1.05 [0.92-1.19],0.4801426396074979
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral cysts,24190,179,1.04 [0.86-1.27],0.6803375116583135
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24432,202,1.02 [0.85-1.22],0.8719317678673048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,24377,21,0.81 [0.45-1.44],0.4743490967192154
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24499,50,1.30 [0.91-1.85],0.1532630033298928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",24062,51,0.85 [0.59-1.23],0.3908353904067037
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Epilepsy,23125,234,1.09 [0.92-1.29],0.3390946854530385
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,24077,1186,1.07 [1.00-1.16],0.0640510134871085
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24482,166,1.10 [0.90-1.35],0.3383030000643472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24059,1481,0.99 [0.92-1.06],0.7493154160820343
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Generalized epilepsy,24175,47,1.09 [0.75-1.59],0.6530773580724734
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hemiplegia,24378,148,0.96 [0.78-1.19],0.729154825527514
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hydrocephalus,24055,44,1.47 [1.00-2.14],0.0477120738236426
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24489,62,1.34 [0.97-1.85],0.0731787438719012
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,23023,69,0.87 [0.63-1.20],0.404762698084421
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,23027,73,1.13 [0.84-1.53],0.4224613923547243
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Memory loss,24378,67,0.99 [0.72-1.37],0.9621273647138764
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Migraine,23266,375,1.18 [1.04-1.35],0.0130728973150656
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24432,338,1.17 [1.02-1.35],0.0255302769174809
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Motor neuron disease,17822,91,1.16 [0.89-1.52],0.2753767519563549
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24316,133,0.94 [0.75-1.18],0.605092632093429
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23966,1012,1.04 [0.96-1.13],0.3159410235658266
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Neurological diseases,23213,2699,1.04 [0.99-1.09],0.1187109515866055
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,24424,68,1.11 [0.81-1.51],0.5195228847441111
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",23302,348,1.01 [0.88-1.16],0.8573839695269608
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24448,206,1.10 [0.92-1.32],0.2767733480006792
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20443,282,0.96 [0.82-1.13],0.6293770425574945
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,24064,53,1.01 [0.71-1.44],0.958199562257894
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other disorders of nervous system,24118,107,0.97 [0.75-1.25],0.8222162738122993
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24387,71,1.09 [0.81-1.48],0.5680835524163435
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other facial nerve disorders,23039,85,0.93 [0.70-1.23],0.5980129384305239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other headache syndromes,22946,55,1.02 [0.72-1.46],0.8937373164604299
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other neurological diseases,24402,391,1.09 [0.95-1.24],0.2197384082478254
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other sleep disorders,23414,523,1.04 [0.93-1.17],0.4871910653803182
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Parkinson's disease,24497,76,1.09 [0.81-1.47],0.5762996176674846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,24067,56,1.20 [0.85-1.69],0.3114743436270403
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Restless leg syndrome,24509,33,1.14 [0.73-1.78],0.573876959440849
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Sleep apnoea,24291,455,1.04 [0.92-1.17],0.5525151392770926
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24274,32,1.36 [0.87-2.13],0.1772607508356469
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24494,116,1.03 [0.81-1.32],0.7928201388262666
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22982,28,1.07 [0.65-1.74],0.7979539773437856
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24510,65,0.81 [0.58-1.13],0.2180133479097334
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),24399,16,0.90 [0.46-1.74],0.7453053640328975
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,24080,36,0.95 [0.62-1.47],0.8297010823178166
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,24186,187,0.95 [0.78-1.15],0.5753920552958972
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24433,171,1.05 [0.86-1.27],0.6373365670340634
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23843,34,1.21 [0.78-1.88],0.4025235152330481
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23876,67,1.12 [0.82-1.54],0.4671018221168947
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24430,29,0.85 [0.52-1.39],0.5183927565413474
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,24337,55,1.18 [0.84-1.67],0.3437428730247219
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1503,36,1.51 [0.97-2.33],0.0655001021563152
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1776,71,0.96 [0.70-1.31],0.8009465077851998
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,24118,74,1.05 [0.78-1.43],0.7346320315052224
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24401,556,1.08 [0.97-1.20],0.1748715231396322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",24233,424,0.94 [0.83-1.07],0.3479866471230104
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23931,122,0.83 [0.66-1.06],0.1381967820079716
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24426,427,1.03 [0.91-1.17],0.6077341711650919
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24502,49,1.02 [0.70-1.48],0.9217040165976804
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24356,357,1.03 [0.90-1.18],0.6931544840316057
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24473,191,1.02 [0.85-1.23],0.8263168630165968
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24451,121,0.93 [0.73-1.18],0.5399418552369384
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23824,15,0.83 [0.42-1.65],0.5926952158203005
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23836,27,1.28 [0.78-2.10],0.3264937089526849
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23839,30,0.79 [0.49-1.29],0.3496421412503327
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24468,346,1.06 [0.92-1.22],0.4115946257514696
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,24206,84,0.84 [0.63-1.13],0.2539482811433439
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,24021,22,1.08 [0.62-1.87],0.79835175130639
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,24345,63,1.14 [0.82-1.58],0.4394010489291917
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24412,130,1.00 [0.80-1.26],0.9843586985164908
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,24146,147,1.11 [0.89-1.37],0.3531402687325323
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24399,69,1.00 [0.73-1.36],0.9803788648955732
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,24348,226,1.20 [1.01-1.42],0.035789401473986
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,24145,101,1.26 [0.98-1.63],0.0706805483936387
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23877,966,1.12 [1.03-1.22],0.0067412968968826
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24390,108,1.02 [0.79-1.31],0.8841105285460457
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24489,102,1.16 [0.90-1.50],0.2396312025263212
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,24044,235,1.01 [0.86-1.20],0.873069045471696
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,24318,36,1.00 [0.64-1.54],0.9869417991271818
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24487,34,1.01 [0.65-1.59],0.952172169955932
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23844,35,1.06 [0.68-1.64],0.806500777842641
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23913,104,0.98 [0.76-1.26],0.8616783093028187
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23903,58,0.93 [0.66-1.32],0.6952251095770272
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,24050,51,1.19 [0.83-1.71],0.3448674694222265
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23894,49,0.93 [0.64-1.35],0.7089175832643606
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,24170,48,1.18 [0.81-1.71],0.3820274508101774
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",24204,82,0.82 [0.61-1.10],0.192968608442003
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23884,75,1.18 [0.88-1.59],0.2746777948238876
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23954,109,1.37 [1.07-1.75],0.0111914151513591
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23875,30,1.27 [0.79-2.03],0.3256914487174774
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23648,737,1.06 [0.97-1.17],0.2177894192682969
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23852,43,0.77 [0.51-1.15],0.198275600121955
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24318,274,1.12 [0.96-1.31],0.1460114507093066
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,24076,32,0.93 [0.58-1.48],0.7581355903314627
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),24157,113,1.12 [0.88-1.43],0.3615536810737232
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,24328,57,0.92 [0.65-1.31],0.6442850231635191
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24469,84,1.01 [0.76-1.35],0.9325824194980468
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24398,127,1.00 [0.80-1.26],0.9873814445895364
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,24323,52,1.02 [0.71-1.47],0.9028314184968116
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,24321,50,1.05 [0.73-1.52],0.7858798905090434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24425,482,1.02 [0.90-1.14],0.7831863438273698
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,24242,299,1.04 [0.90-1.21],0.5891912430224132
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,24031,88,1.01 [0.76-1.33],0.9419298863525668
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,24014,71,1.04 [0.76-1.41],0.8065287049986644
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute pharyngitis,24247,67,0.75 [0.54-1.04],0.0849776062276822
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24390,210,0.93 [0.77-1.11],0.4205010353586852
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,24238,58,1.03 [0.73-1.45],0.8705119416240221
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,All influenza,23355,70,0.98 [0.72-1.34],0.8946249749208146
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),23354,69,1.00 [0.73-1.37],0.9998535092201049
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Allergic asthma (mode),18135,123,1.14 [0.90-1.44],0.2690629620200283
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Allergic rhinitis,24384,283,1.16 [0.99-1.35],0.0604611171930054
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19452,1575,1.07 [1.00-1.14],0.0503799845824637
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19557,1545,1.07 [1.00-1.14],0.0406518886404738
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),24257,86,1.29 [0.98-1.70],0.0688876303400212
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",23337,52,1.61 [1.14-2.28],0.0073737548955987
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Bronchiectasis,21788,160,1.26 [1.03-1.54],0.026103071020038
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21662,34,1.10 [0.70-1.72],0.685957798543162
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23729,2101,1.07 [1.01-1.13],0.0199087349999161
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23184,58,0.97 [0.69-1.36],0.8483142282485121
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic sinusitis,23273,147,1.28 [1.04-1.58],0.0213926133949541
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24417,643,1.05 [0.95-1.17],0.3161533793510733
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Deviated nasal septum,23246,120,0.93 [0.73-1.18],0.5480549015396159
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22785,3779,1.07 [1.03-1.12],0.0015439518536948
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23472,346,0.95 [0.83-1.10],0.4902255932043846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Early onset COPD,24239,465,1.07 [0.95-1.20],0.2975548200564708
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Emphysema,21795,167,0.58 [0.47-0.72],6.582319936123288e-07
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23362,100,0.99 [0.76-1.28],0.94123886317667
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24347,1062,1.06 [0.98-1.15],0.1243631012039015
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Interstitial lung disease,23384,122,1.07 [0.85-1.35],0.5785877225663374
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Later onset COPD,23198,178,1.02 [0.84-1.24],0.8166315962526031
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24501,137,0.96 [0.77-1.20],0.7018370253859644
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Nasal polyp,23231,105,1.16 [0.90-1.49],0.2512583846120628
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24314,562,1.14 [1.02-1.27],0.020372486670223
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of pleura,24347,1112,1.17 [1.08-1.26],8.753302971235907e-05
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23927,801,1.08 [0.99-1.18],0.0969420638935288
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other pleural conditions,23268,33,1.24 [0.79-1.93],0.3496847005237036
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24455,179,1.03 [0.85-1.25],0.7496200615902002
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24436,761,1.20 [1.09-1.32],0.0001172738344506
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural effusion,23769,534,1.15 [1.03-1.29],0.01125751708683
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural plaque,23284,49,1.29 [0.90-1.85],0.173232842830667
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",24158,873,1.04 [0.96-1.14],0.3493226595349712
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24484,120,0.96 [0.76-1.22],0.7416918883319851
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pneumothorax,23292,57,1.58 [1.13-2.21],0.0068696019192277
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pollen allergy,24482,243,1.11 [0.94-1.31],0.2188622251385095
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pulmonary oedema,24312,36,1.03 [0.67-1.59],0.8759733549968248
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Respiratory insufficiency,18045,33,1.44 [0.93-2.24],0.1008795998105708
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24294,542,1.11 [1.00-1.24],0.0601612450493334
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23409,283,1.16 [1.00-1.35],0.0574741467284738
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Viral pneumonia,23452,167,1.13 [0.92-1.38],0.2339183777253769
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",24271,144,1.11 [0.89-1.38],0.3437883625676555
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,14120,89,0.81 [0.61-1.07],0.1416889080468686
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18753,59,1.11 [0.80-1.55],0.5348569761501747
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute appendicitis,24331,135,0.81 [0.64-1.02],0.0690849850666693
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute gastritis,19578,62,0.96 [0.69-1.34],0.824892630188802
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis,23081,154,1.08 [0.88-1.33],0.4568377822210373
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute peritonitis,24105,61,1.14 [0.82-1.58],0.437403524171355
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23818,76,0.90 [0.66-1.21],0.4681732126884503
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Barrett oesophagus,19832,316,1.00 [0.86-1.16],0.9817487587310036
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22977,50,0.89 [0.61-1.29],0.5393036100345512
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",24146,50,0.88 [0.61-1.28],0.5154443020188475
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholecystitis,23082,155,1.00 [0.81-1.23],0.9635434765577476
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholelithiasis,23755,828,1.03 [0.94-1.12],0.5918964559402651
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic gastritis,19735,219,1.10 [0.92-1.31],0.3056905662844644
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22966,39,0.97 [0.64-1.48],0.8954059067672001
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24380,77,0.81 [0.60-1.09],0.1686003633780436
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Coeliac disease,23242,94,1.17 [0.89-1.52],0.2611210037794746
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Collagenous colitis,23118,49,1.13 [0.78-1.64],0.5141492620719297
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24338,186,1.02 [0.84-1.23],0.8309643095833632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Constipation,24314,1030,1.05 [0.97-1.14],0.2499819797501276
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn disease,23152,83,1.01 [0.76-1.34],0.9451871646327282
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24197,55,0.93 [0.65-1.33],0.7022383763313472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn's disease NAS,23147,78,1.06 [0.79-1.42],0.7111418122149424
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Dental caries,23761,234,1.16 [0.98-1.38],0.0818323952394079
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22644,1597,1.06 [1.00-1.14],0.0623364445982786
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of appendix,24368,172,0.94 [0.77-1.15],0.5745408288986562
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of liver,24401,659,1.02 [0.92-1.13],0.7061186430015504
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22956,3440,1.03 [0.98-1.07],0.2519478924801471
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",24070,543,1.14 [1.02-1.27],0.0249941181188826
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24432,388,1.16 [1.02-1.32],0.0267777445551131
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23644,117,1.18 [0.93-1.49],0.1780535903874074
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23502,62,1.01 [0.72-1.40],0.9753889119351216
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of the digestive system,24259,1111,1.10 [1.02-1.19],0.0118476599272206
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of tongue,23509,109,0.96 [0.74-1.23],0.7395478143285927
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",24050,1123,1.01 [0.94-1.09],0.771506410163814
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20857,2163,1.07 [1.01-1.13],0.016615124723433
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Duodenal ulcer,19650,134,1.01 [0.81-1.27],0.9011678680040376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24444,103,0.98 [0.76-1.26],0.863143641607396
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24389,70,1.41 [1.04-1.91],0.0254481598996784
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23837,95,0.91 [0.69-1.18],0.4679937339417002
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18854,160,0.99 [0.81-1.21],0.9203555332308344
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Functional dyspepsia,19978,462,1.01 [0.89-1.14],0.8812595767833177
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastric ulcer,19769,253,0.93 [0.79-1.09],0.374083466310942
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21512,1996,1.06 [1.00-1.12],0.0471653297732844
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19887,371,0.97 [0.84-1.11],0.6239523811194285
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19942,7107,1.04 [1.01-1.07],0.0212007732766687
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,GI-bleeding,24044,896,1.07 [0.98-1.16],0.140265577340761
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23589,62,0.99 [0.71-1.39],0.9658145314721108
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19496,1130,1.09 [1.01-1.17],0.0339006257123736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23788,46,1.01 [0.69-1.48],0.9567811575101944
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Hernia,23465,2418,1.06 [1.00-1.11],0.0424897944137555
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impacted teeth,24399,65,1.53 [1.12-2.09],0.0071870003662218
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impaction of intestines,18727,33,1.58 [1.02-2.44],0.0409992113920819
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Inguinal hernia,21655,608,1.02 [0.92-1.13],0.7057635418557326
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",21118,71,0.95 [0.70-1.30],0.7514154721672767
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18759,65,0.91 [0.65-1.26],0.5727123431971353
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23262,114,1.29 [1.01-1.64],0.0396936121977574
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19207,513,1.07 [0.96-1.20],0.2296826254863465
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24485,342,1.12 [0.98-1.29],0.1023813509494209
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23683,614,1.06 [0.96-1.18],0.2645466101647161
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23846,777,1.09 [0.99-1.19],0.0720940086099749
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19648,132,1.41 [1.13-1.75],0.0020282501662944
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophagitis,19954,438,1.12 [0.99-1.26],0.0787279704180848
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24470,121,1.05 [0.83-1.33],0.7034459006895495
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,21091,44,1.32 [0.90-1.94],0.1583035646374818
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19847,1153,1.00 [0.93-1.08],0.962931067643574
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,23101,174,0.97 [0.79-1.18],0.7416739660297353
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,23071,144,0.95 [0.76-1.18],0.629446988329132
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestine,20048,1354,1.01 [0.94-1.08],0.8457704059279554
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestines,23039,4345,1.03 [0.99-1.08],0.0961589734059849
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23507,176,1.05 [0.86-1.27],0.6593792642870244
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of liver,24271,529,1.01 [0.91-1.14],0.8112604601536805
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19998,482,0.99 [0.88-1.11],0.8519566882530203
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of pancreas,23003,76,1.08 [0.80-1.45],0.6057778774652327
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24384,340,1.17 [1.02-1.35],0.0249638770115949
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20197,681,1.01 [0.91-1.12],0.8567032216013333
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,24055,907,1.07 [0.98-1.17],0.126838161398536
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23680,153,1.07 [0.86-1.32],0.5557405529467879
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19768,1074,1.06 [0.98-1.15],0.1385688617922329
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21085,1569,0.99 [0.93-1.06],0.8645708006951945
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23816,74,0.89 [0.65-1.21],0.4531650004964342
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23742,673,1.06 [0.96-1.17],0.2552810034830458
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18911,217,1.23 [1.04-1.47],0.0173590005883322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24374,83,1.31 [0.99-1.73],0.0612947931267758
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19013,319,1.11 [0.96-1.28],0.1543022673356357
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23273,125,1.27 [1.01-1.60],0.0413459793795475
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24500,55,0.87 [0.61-1.24],0.4316113988970731
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23540,117,0.98 [0.77-1.25],0.8945871287853709
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Toxic colitis,23092,23,0.98 [0.57-1.70],0.9489352975143648
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19690,174,1.20 [0.99-1.46],0.0671938052333844
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcerative colitis,23203,134,1.35 [1.09-1.68],0.0068194708001858
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23186,117,1.33 [1.05-1.68],0.0179214198500877
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Umbilical hernia,21291,244,0.95 [0.81-1.13],0.5846266755028015
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18791,97,1.23 [0.95-1.60],0.1162808292032607
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ventral hernia,21255,208,1.16 [0.97-1.39],0.0946455945210434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Volvulus,18753,59,0.94 [0.67-1.33],0.730914973220967
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24468,138,0.98 [0.78-1.22],0.849608801260874
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,24276,75,0.89 [0.66-1.21],0.4552613371231401
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23189,135,1.04 [0.83-1.30],0.7205147945397792
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23932,492,1.01 [0.90-1.14],0.8218022059936093
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23624,184,1.06 [0.87-1.28],0.563835523883521
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,23205,151,1.14 [0.92-1.40],0.2332926577221239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,24279,207,1.13 [0.95-1.35],0.1761739132067138
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24422,350,1.10 [0.96-1.26],0.1880289586469439
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,24112,40,1.32 [0.88-1.97],0.1799160201437493
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23206,2293,1.04 [0.99-1.10],0.128885440630978
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,24099,383,0.93 [0.82-1.07],0.3246319972208274
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23985,269,0.91 [0.78-1.07],0.2538959474887411
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,24151,711,1.01 [0.91-1.11],0.8685127451267859
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24499,42,1.25 [0.84-1.85],0.2708641090104939
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,23109,55,1.05 [0.74-1.49],0.7819117328955562
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23753,37,1.49 [0.99-2.24],0.0577357420854189
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,24273,201,1.12 [0.94-1.35],0.2071023625545388
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23317,263,1.15 [0.98-1.35],0.0908665912738211
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,23088,34,1.30 [0.84-2.01],0.2467413399388088
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24434,66,1.15 [0.84-1.58],0.3895148557587303
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23562,122,1.15 [0.91-1.45],0.2520313034730028
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24334,133,0.78 [0.62-0.98],0.033593460732377
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,24097,25,0.88 [0.52-1.52],0.6571547215132135
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,23102,48,0.90 [0.61-1.31],0.5755482433862227
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,24052,998,1.08 [1.00-1.17],0.0598773053833696
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23347,293,1.20 [1.03-1.40],0.0164658675758355
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,23092,38,1.42 [0.94-2.14],0.0968237356834281
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24437,236,0.91 [0.76-1.07],0.2526541645579258
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,24126,54,0.83 [0.58-1.20],0.3249988223011908
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24393,192,0.86 [0.71-1.04],0.1121481996908113
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24483,153,0.96 [0.77-1.18],0.6805646713734903
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,23167,113,1.10 [0.86-1.40],0.4583847264082904
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,23228,174,0.98 [0.81-1.20],0.873691019269012
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24477,147,0.96 [0.77-1.19],0.7057146262124045
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",23171,117,1.16 [0.91-1.47],0.2316708643937702
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24479,111,1.17 [0.92-1.50],0.2043714500085805
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21488,120,1.06 [0.84-1.34],0.639394382769336
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22857,4141,1.01 [0.97-1.05],0.657478770094623
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21650,2934,1.01 [0.97-1.06],0.5738008081586969
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21455,87,1.01 [0.77-1.34],0.9222942310707448
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21969,137,1.02 [0.82-1.28],0.8380791748850394
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21975,143,1.14 [0.92-1.41],0.2476211526253714
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,24303,108,0.78 [0.60-1.01],0.0548680054804557
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21874,42,0.75 [0.50-1.13],0.1713667956907974
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19382,666,0.98 [0.88-1.08],0.6806769229645261
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24453,111,1.01 [0.79-1.30],0.9358333187949252
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,22088,256,1.07 [0.91-1.26],0.4129632424438176
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21409,5549,1.02 [0.99-1.06],0.2604750473761497
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23261,100,0.91 [0.70-1.19],0.4889904209775219
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21478,110,0.90 [0.70-1.15],0.3901764530708509
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21924,556,1.03 [0.92-1.15],0.5877355636820798
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23707,1875,1.05 [0.99-1.11],0.1414169829227343
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21572,204,1.21 [1.01-1.45],0.0361230883978322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21630,262,1.20 [1.02-1.41],0.0251334264892936
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21507,139,1.17 [0.94-1.45],0.1722546972133006
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,24025,33,0.76 [0.47-1.22],0.253982854703573
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19878,1162,1.04 [0.96-1.12],0.377479059440255
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19063,347,1.05 [0.92-1.20],0.4886371205483903
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24462,337,1.07 [0.93-1.23],0.3540575351978047
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18784,68,0.89 [0.64-1.23],0.4812160781355296
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19028,312,0.86 [0.74-1.00],0.0452568375174223
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21663,295,1.01 [0.87-1.18],0.8696884899521958
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19393,677,0.99 [0.89-1.09],0.8264714746233384
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21855,23,0.66 [0.38-1.16],0.1499995782942648
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,22331,499,1.08 [0.96-1.21],0.2003674826751325
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,22088,256,1.03 [0.87-1.21],0.7447840412677291
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19342,626,0.97 [0.87-1.07],0.5194708027497931
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21440,72,1.27 [0.94-1.71],0.1178711535534339
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21422,54,1.09 [0.77-1.56],0.6219331757000932
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,23215,54,1.13 [0.80-1.60],0.4977655679412673
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24212,1051,1.03 [0.95-1.11],0.5280161988869417
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23755,594,1.07 [0.96-1.19],0.2265269313385894
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24405,311,1.11 [0.95-1.28],0.1783236155891581
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,20316,1600,1.02 [0.95-1.09],0.6193164669436724
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18783,67,0.90 [0.65-1.25],0.5302263422242626
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21439,71,1.01 [0.74-1.38],0.949406816663934
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18742,26,0.80 [0.47-1.35],0.4069724494839297
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18818,102,0.99 [0.77-1.29],0.9607679953050516
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23375,214,0.94 [0.78-1.13],0.4951479369969115
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,23385,224,1.05 [0.88-1.25],0.5970406473900428
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24474,78,1.01 [0.75-1.35],0.969552419640332
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23228,1396,1.09 [1.02-1.17],0.0170753791333862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21477,109,0.81 [0.63-1.05],0.1123841763267201
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18828,112,0.75 [0.58-0.96],0.0246850121034616
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,22398,566,1.02 [0.91-1.14],0.7538058416449263
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20542,1826,0.99 [0.93-1.05],0.6721654619312748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,24044,52,0.84 [0.58-1.22],0.3553480467385055
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24485,70,0.96 [0.70-1.31],0.7958639366950682
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21438,70,1.09 [0.80-1.49],0.5729867849375738
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",22347,979,1.05 [0.96-1.14],0.2961679306068162
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21431,63,0.96 [0.69-1.34],0.8113329205644352
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19723,1007,1.07 [0.99-1.16],0.1086865094629634
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23257,96,1.04 [0.80-1.36],0.7677142181386896
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21427,59,0.93 [0.66-1.31],0.66590791968194
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21937,105,0.92 [0.71-1.19],0.5093667953433363
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21720,352,0.97 [0.85-1.12],0.69709848879756
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24184,192,1.04 [0.86-1.25],0.7059257891966498
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,22257,425,1.16 [1.02-1.31],0.0213856063062865
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24414,296,1.12 [0.96-1.30],0.1446732290216636
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24494,35,0.84 [0.54-1.32],0.4608708407006801
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21557,189,0.97 [0.80-1.18],0.773562261685393
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19649,550,1.08 [0.97-1.21],0.1592943291019131
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21805,437,0.96 [0.85-1.09],0.5573634355704467
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21518,150,1.23 [1.00-1.52],0.0520705839048648
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18751,35,0.72 [0.46-1.14],0.1591902891948878
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20300,1584,1.06 [0.99-1.13],0.0871133888410194
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19118,402,0.93 [0.81-1.06],0.2518490861942906
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,24069,77,1.14 [0.85-1.53],0.3802497636224261
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24441,45,0.96 [0.65-1.42],0.8298842829248577
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",23080,26,1.13 [0.68-1.87],0.6436337923757794
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18788,72,0.95 [0.70-1.29],0.7256842334072178
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21916,84,1.17 [0.88-1.55],0.2770913437846434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19031,315,1.11 [0.96-1.29],0.1660637789346749
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21607,239,0.95 [0.80-1.12],0.5278778703735922
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,22024,192,1.25 [1.04-1.51],0.0158787851851677
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21926,94,0.99 [0.75-1.29],0.9161541969552616
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20724,43,1.40 [0.94-2.07],0.0949281551320058
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24497,38,0.81 [0.53-1.26],0.3542122949561781
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21903,535,0.98 [0.88-1.10],0.7399930906244883
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],24071,79,0.93 [0.69-1.26],0.6489830759250783
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23542,2174,1.01 [0.95-1.07],0.7545025493753177
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21470,102,0.89 [0.69-1.16],0.4025261639552068
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,22157,325,1.04 [0.90-1.20],0.611122454984987
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,23244,172,1.05 [0.86-1.28],0.6362982410044502
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21968,136,1.12 [0.90-1.40],0.31498907589744
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22796,964,0.98 [0.90-1.07],0.6948694227527711
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22465,633,0.94 [0.85-1.05],0.2582741059382921
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21408,40,0.93 [0.61-1.42],0.7420639327889269
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24135,143,1.15 [0.92-1.43],0.2148663679421789
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21507,139,1.11 [0.89-1.38],0.3523068709269964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21422,54,0.75 [0.52-1.08],0.1218231983774507
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18749,33,0.88 [0.55-1.39],0.5739458254039709
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24051,755,1.15 [1.05-1.26],0.003112819121799
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9933,65,1.01 [0.73-1.41],0.9344521476100256
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13222,74,0.80 [0.59-1.10],0.1707320064356887
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24243,277,1.01 [0.86-1.18],0.9424053205261272
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,24021,55,0.79 [0.55-1.13],0.2023214228327478
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23861,565,1.16 [1.04-1.29],0.008151420002676
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24346,20,0.61 [0.34-1.11],0.1047572718363602
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24357,165,0.98 [0.80-1.20],0.8101866944464997
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cystitis,22512,138,1.09 [0.87-1.36],0.4469365868919217
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Dialysis,23340,44,1.37 [0.94-2.00],0.1007572685611158
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10617,1012,1.10 [1.02-1.20],0.0164395967261867
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13327,179,0.89 [0.73-1.09],0.2538248306164566
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Endometriosis,9985,117,1.01 [0.79-1.29],0.9463875839174688
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10206,338,0.88 [0.76-1.01],0.077873989999829
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10252,384,1.04 [0.91-1.19],0.5502987343674131
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20667,3775,1.06 [1.01-1.10],0.009895658525468
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24387,61,1.24 [0.90-1.72],0.195289350930236
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hydrocele,9676,71,1.10 [0.81-1.49],0.5366615193249367
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,23214,196,1.15 [0.95-1.38],0.1460905334487176
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10281,676,1.12 [1.01-1.24],0.0254658330791472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13206,212,1.00 [0.83-1.20],0.9906271543323956
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9696,91,0.94 [0.71-1.24],0.6647305642590475
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Irregular menses,13210,107,0.70 [0.54-0.91],0.008061984873064
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10134,266,1.01 [0.86-1.19],0.9011683048080144
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22432,58,1.08 [0.77-1.52],0.6500280885635348
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11120,1252,1.00 [0.93-1.08],0.9507226817576364
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9652,47,1.15 [0.79-1.67],0.4683482837047213
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9955,87,1.34 [1.02-1.77],0.0378325589459929
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24500,36,1.22 [0.80-1.88],0.3589822430069878
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24505,42,1.04 [0.69-1.55],0.8565487287428123
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23734,1360,1.12 [1.04-1.20],0.00155924288974
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22805,431,1.14 [1.01-1.29],0.0383714454112144
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13203,55,1.08 [0.76-1.54],0.6543185673884645
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24463,271,1.10 [0.94-1.28],0.2556971877318938
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9746,141,1.02 [0.82-1.26],0.8798204469007473
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9711,106,1.13 [0.89-1.45],0.3200267666063351
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9672,67,1.14 [0.83-1.56],0.4237651621242548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24478,48,0.99 [0.68-1.44],0.9575891333174824
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,23372,998,1.11 [1.03-1.21],0.0106380268533003
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13103,109,1.12 [0.87-1.44],0.386752298078834
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9940,72,1.20 [0.88-1.63],0.2465949888618328
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10074,206,1.13 [0.94-1.35],0.1987863302183052
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9922,54,1.37 [0.97-1.95],0.0771586522858282
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9964,96,1.27 [0.98-1.66],0.0739309985121503
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,23246,228,1.12 [0.94-1.33],0.1988468527123114
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,24285,93,1.14 [0.88-1.49],0.328090308257303
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,10027,159,1.07 [0.87-1.32],0.525365708451526
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9938,70,0.92 [0.67-1.27],0.6198280344796985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10243,375,0.99 [0.87-1.14],0.9044349528415284
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9925,57,1.10 [0.78-1.55],0.5920839839338967
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10197,329,0.98 [0.85-1.14],0.8378975521194518
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24368,42,1.17 [0.79-1.74],0.4356296204165174
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9703,98,1.42 [1.10-1.82],0.0061327143702814
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24349,1331,1.13 [1.05-1.21],0.0007676777493152
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",23145,127,1.17 [0.93-1.48],0.1677060415400997
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23354,58,0.98 [0.69-1.38],0.888436993829179
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,24027,61,1.00 [0.72-1.39],0.9995972735905369
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22527,153,1.25 [1.01-1.53],0.0376657934037799
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24300,334,0.97 [0.84-1.12],0.7209371632277597
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9956,88,1.00 [0.75-1.32],0.9756002033992802
